Market Tracker

10/24 12:53pm ET

Dynavax Technologies Corp (NASDAQ:DVAX)

1.58
Real-Time Quote
 +0.05 / +3.27%
Today’s Change
1.10
Today|||52-Week Range
2.14
-19.39%
Year-to-Date

Today’s Trading

Previous close1.53
Today’s open1.53
Day’s range1.52 - 1.61
Volume2,415,838
Average volume (3 months)1,643,105
Market cap$402.2M
Dividend yield--
Data as of 12:38pm ET, 10/24/2014

Growth & Valuation

Earnings growth (last year)+7.32%
Earnings growth (this year)+11.05%
Earnings growth (next 5 years)--
Revenue growth (last year)+15.82%
P/E ratioNM
Price/Sales34.19
Price/Book2.16

Competitors

 Today’s
change
Today’s
% change
SCLNSciClone Pharmaceuti...0.000.00%
XNPTXenoport Inc+0.18+2.81%
ZFGNZafgen Inc+0.05+0.25%
AKBAAkebia Therapeutics ...+0.53+2.75%
Data as of 12:50pm ET, 10/24/2014

Financials

Next reporting dateOctober 30, 2014
EPS forecast (this quarter)-$0.09
Annual revenue (last year)$11.3M
Annual profit (last year)-$66.7M
Net profit margin-593.01%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Eddie J. Gray
Senior Vice President-Operations &
Quality
David F. Novack
Corporate headquarters
Berkeley, California

Forecasts